CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹376 Cr | ₹300 Cr | ₹242 Cr | ₹21,501 Cr | ₹177 Cr |
What is the latest Consolidated Net Profit of CAPLIN POINT LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹376 Cr |
Mar2023 | ₹300 Cr |
Mar2022 | ₹242 Cr |
Mar2021 | ₹21,501 Cr |
Mar2020 | ₹177 Cr |
How is Consolidated Net Profit of CAPLIN POINT LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹376 Cr | 25.49 | |
Mar2023 | ₹300 Cr | 23.76 | |
Mar2022 | ₹242 Cr | -98.87 | |
Mar2021 | ₹21,501 Cr | 12,077.96 | |
Mar2020 | ₹177 Cr | - |
Compare Consolidated Net Profit of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹15,965.7 Cr | 4.1% | 0.7% | 37% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | 4.1% |
0.7% |
37% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses